The development of new nano immunization drugs in two universities in Taiwan can reduce the side effects of chemotherapy.


The development of new nano immunization drugs in two universities in Taiwan can reduce the side effects of chemotherapy.

Original title: Taiwan two colleges and universities to develop nano immune new drugs can reduce side effects of chemotherapy

China and the new network, June 13, according to Taiwan "Wang Bao" reported that National Chiao Tung University and Taiwan "China Medical University" cooperation, the joint development of nano immune brown alga drugs, this new drug not only have immune regulation function, significantly improve the effect of immunotherapy on cancer treatment, increased anti-cancer ability, but also reduce immunotherapy And the side effects caused by chemotherapy help to treat cancer. Both schools are actively applying for international patents.

In recent years, in the field of cancer treatment, immunotherapy is one of the most promising ways to end cancer. The principle of immunotherapy is to regulate the immune system of the human body, to reactivate the immune cells to the cancer cells, and to remove the cancer cells to achieve the purpose of cancer treatment.

According to the Nature Review academic journal, by 2024, immunotherapy will be the world's most important cancer treatment strategy and will account for more than 6 of the cancer market. However, immunotherapy is only effective for some patients, and this kind of immunosuppressive agent can affect the human immune system, which is the reaction of skin ulceration and gastric ulcers when immune cells attack cancer cells.

Chen Sanyuan, a professor of Materials Department of National Chiao Tung University, and Xu Weicheng, vice president of the center for translation medicine of China University of medicine in Taiwan, made up a team by Professor Xu Weicheng, a professor of Materials Department of the Chinese Medical University in Taiwan. Iron oxide particles, and through the design of nanoscale drug carrier, combine immuno - whistle inhibitor with T cell proliferative agent into a single nanoscale system to form anticancer drugs with anti-cancer function and can reduce human side effects.

The research team found that the study not only significantly extended the survival cycle, as well as reducing side effects, and was expected to provide a new treatment platform for drug delivery, biomedical materials, and immunotherapy. The results of this study have been published in the internationally renowned Journal Nature Nanotechnology May.

"Chemotherapy is like poison," Chen Sanyuan said. The nano - immune fucose drug has a breakthrough advantage in the treatment of cancer. It does not only significantly reduce the side effects caused by immunization and chemotherapy, reducing the cancer patients at the chemotherapy stage and prone to nausea, hair loss, and blood cell degradation, and the use of dose as long as possible. One percent, we can achieve the effect of removing tumor. The new drug has been applied for patent in China, Taiwan, the United States, the European Union and Japan.

It

Responsible editor: Gui Qiang


Waonews is a news media from China, with hundreds of translations, rolling updates China News, hoping to get the likes of foreign netizens